Canopy divests medical cannabis manufacturing facility in Denmark.
Little Green Pharma (LGP) has acquired a fully operational, GMP medicinal cannabis cultivation and manufacturing facility in Denmark from CGC. The C$20M acquisition of the 21,500 m2 cultivation and 4,000 m2 GMP manufacturing facility positions LGP as the leading Australian medicinal cannabis producer and owner of one of the highest-quality cannabis production facilities in Europe. The facility, located in Northern Odense, has the capacity to produce more than 12 tonnes per annum of finished flower and provides LGP with much-needed product supply from its current inventory of ~1 tonne of medicinal cannabis flower products. The LGP Group plans to immediately focus on delivering products in Australia and Germany as it grows its portfolio of export destinations over time. In addition, the facility is well advanced for its first medicinal cannabis products for the Danish market, with current plans to release in early 2022.
AYR Growth Continues (AYRWF)
AYRWF is a LONG
Ayr Wellness Inc. announced today the opening of the third Ayr medical dispensary in the Commonwealth of Pennsylvania, located in Gibsonia, a suburb of Pittsburgh. The Ayr Wellness dispensary is the third in the state opened by CannTech PA, LLC, a wholly-owned Ayr subsidiary. The strategic location, just off Route 8 at 112 Northtowne Square, Gibsonia, PA 15044, will see over 33,000 cars drive by per day
Clever Leaves (CLVR)
A few more announcements like this, and CLVR will be in a stronger position. Clever Leaves Holdings Inc. (CLVR) announced a commercial agreement with a pharmaceutical manufacturing company, IDT Australia Limited, for Clever Leaves to supply to IDT two varieties of bulk GACP1 certified flower from its facility in Portugal. Clever Leaves has made its first commercial shipment of high-THC dried flower to Australia as part of the commercial arrangement. In line with its international strategy, Clever Leaves aims to widen its distribution channel with IDT and expand its product portfolio to service and meet the demand of the Australian market.
